Akebia Therapeutics Inc. - AKBA - stock price prediction, stock price target, analyst ratings from 4 analysts
Akebia Therapeutics Inc. has a share price target of US$ 7, revenue growth forecast of 20.1%, and profit growth estimate of 31.3% for FY25, based on top 4 analyst calls.